Chongqing Precision Biotech Co., Ltd clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   2 trials marked Unknown by the registry's verification sweep

   1. Minor

      Research About CD70-targeted CAR-T · CD70-positive…Research About CD70-targeted CAR-T · CD70-positive Advanced/Metastatic Solid Tumors

      Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Recruiting

      Chongqing Precision Biotech Co., Ltd·Phase 1· NCT06010875· Registry history of NCT06010875 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   2. Minor

      CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic…CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

      Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Recruiting

      Chongqing Precision Biotech Co., Ltd·Phase 1· NCT06010862· Registry history of NCT06010862 on ClinicalTrials.gov (opens the registry)

      Changed Oct 4, 2026

   Registry verification sweep

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.